Measuring Hematopoietic Cell Proliferation (CFU/CFC Assays)

Measuring Hematopoietic Cell Proliferation (CFU/CFC Assays)

The ability to model human hematopoietic cell differentiation is critical for many areas of biomedical research including drug-induced hematopoietic cell toxicity, bone marrow transplant tolerance, cancer immunotherapy, and autoimmune disorders. CDI’s hematopoietic progenitor cells offer access to commercial quantities of highly pure hematopoietic cells, providing reproducible results for these and other research and therapeutic applications.